HLB Life Science Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Sangwoo Nam
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
The Price Is Right For HLB Life Science Co., Ltd. (KOSDAQ:067630) Even After Diving 41%
Mar 31
We Think Shareholders Should Be Aware Of Some Factors Beyond HLB Life Science's (KOSDAQ:067630) Profit
Mar 27Market Participants Recognise HLB Life Science Co., Ltd.'s (KOSDAQ:067630) Revenues
Feb 11Is HLB Life Science (KOSDAQ:067630) A Risky Investment?
Jan 03HLB Life Science Co., Ltd.'s (KOSDAQ:067630) Popularity With Investors Under Threat As Stock Sinks 26%
Oct 24What HLB Life Science Co., Ltd.'s (KOSDAQ:067630) P/S Is Not Telling You
Aug 30HLB Life Science (KOSDAQ:067630) Shareholders Should Be Cautious Despite Solid Earnings
May 21HLB Life Science Co., Ltd.'s (KOSDAQ:067630) 25% Share Price Surge Not Quite Adding Up
Mar 15HLB Life Science (KOSDAQ:067630) Has Debt But No Earnings; Should You Worry?
Apr 12Did You Participate In Any Of HLB Life Science's (KOSDAQ:067630) Incredible 442% Return?
Feb 14Is HLB Life Science (KOSDAQ:067630) A Risky Investment?
Jan 10We're Not So Sure You Should Rely on HLB Life Science's (KOSDAQ:067630) Statutory Earnings
Dec 06CEO
Sangwoo Nam (68 yo)
Mr. Sangwoo Nam serves as Co-CEO of HLB Life Science Co. Ltd since March 2020 and serves as its Director since March 26, 2020. He is Director of Elevar Therapeutics, Inc. from 2024. He served as Chief Exec...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & Director | 5.7yrs | no data | no data | |
| Co-CEO & Director | no data | no data | no data | |
| Chairman | no data | no data | no data | |
| Independent Outside Director | 1.7yrs | no data | no data | |
| Director | 1.7yrs | no data | no data | |
| Independent Outside Director | 1.7yrs | no data | no data |
Experienced Board: A067630's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/15 22:03 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HLB Life Science Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.